amobarbital has been researched along with Somatoform Disorders in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wijdicks, EFM | 1 |
| Mai, FM | 1 |
2 other studies available for amobarbital and Somatoform Disorders
| Article | Year |
|---|---|
Functional neurology after the Second World War: The beginnings of neurology on screen (III).
Topics: Adult; Amobarbital; Combat Disorders; Diagnosis, Differential; Follow-Up Studies; History, 20th Cent | 2020 |
Briquet's syndrome (hysteria) and the physician.
Topics: Amobarbital; Female; Humans; Hysteria; Male; Psychotherapy; Somatoform Disorders | 1982 |